Drug Candidate Marketplace

Drug Candidate Marketplace lists the information of drug candidates, therapeutic targets and drug discovery technologies. Visitors can use search functions based on the interests and needs and download the list. If you have a drug candidates, therapeutic targets and drug discovery technologies that you are interested in and would like to gain more information, please contact us by clicking the inquiry button. Additional information will be provided to you.

Asset List(PDF) Asset List by Disease Area(PDF) Asset List(Excel)

Date Candidate Mechanism of action Indication Route Modality Development stage Note
06/04/18 GEM019 3rd generation immunotherapy targeting HER2 HER2 overexpressing cancer (Breast) SC Proteins
Preclinical -Applied 3rd generation immunotherapy technology to HER2.
-Superior efficacy to trastuzumab and pertuzumab.
-In-vivo PoC has been validated in non-human primates.
06/04/18 GEM018 3rd generation immunotherapy technology Cancer SC Proteins
Discovery -Unique technology that triggers B and T cells simultaneously while activating all possible natural tumor killing mechanisms available to the immune-system.
-Tumor-directed specific activation reduces side effects to the minimum.
-Applicable on a target basis.
04/10/18 GEM008 Selective cMET inhibitor NSCLC and HCC etc. Oral Small molecules
Phase 2 Effective on exon 14 skipping xenograft
Development by an originator has been discontinued.